Abstract:1. On page e365, left column, the fifth paragraph read, 9. Several studies have evaluated secondary stroke prevention of patent foramen ovale closure since the previous guideline in 2014. It is now considered reasonable to close patent foramen ovale percutaneously in selected patients: those with younger age with nonlacunar stroke or no other cause at any age. It has been updated to read, 9. There have been several studies evaluating secondary stroke prevention of patent foramen ovale closure since the previous guideline in 2014. It is now considered reasonable to percutaneously close patent foramen ovale in patients who meet each of the following criteria: age 18 to 60 years, nonlacunar stroke, no other identified cause, and high risk patent foramen ovale features. 2. On page e374, Figure 2 has been substantively edited as follows: Second row, the green box, "ECG and basic laboratory tests* (Class 1)" has been moved down 1 layer to row 3. Fifth row, the orange box read, "Evaluate for cardiac SOE with TTE or TEE (Class 2b)." The box has been moved up 1 layer to the fourth row; the text has been updated to read, "Echocardiography to evaluate for cardiac SOE (Class 2a)"; and the color of the box changed to yellow in line with the Class of Recommendation change from Class 2b to Class 2a. Fifth row, the green box, the text read, "Non-invasive carotid imaging [CTA, MRA, or US] (Class 1)." It has been updated to read, "Non-invasive cervical carotid imaging [CTA, MRA, or US] (Class 1)." Fifth row, the second yellow box, the text read, "Non-invasive imaging of the intracranial arteries and the extracranial vertebrobasilar arterial system (Class 2a)." It has been updated to read, "Non-invasive intracranial and extracranial imaging of vertebrobasilar arterial system (Class 2a)." Sixth row, the green box, the text read, "Prolonged ECG (Class 1)" It has been updated to read, "Long-term cardiac rhythm monitoring (Class 2a)," and the box color has been changed to yellow in line with the Class of Recommendation change from Class 1 to Class 2a. Sixth row, the second orange box, "PFO screen‡ (Class 2b)" has been removed. Sixth row, the third orange box (now the second box) read, "Test for genetic stroke syndrome (Class 2b)." It has been updated to read, "Test for genetic stroke syndrome (Class 2a)," and the box color has been changed to yellow in line with the Class of Recommendation change from Class 2b to Class 2a. Sixth row, the fourth orange box (now the third box) read, "Test for vasculitis (Class 2b)." It has been updated to read, "Test for infectious vasculitis (Class 2a)," and the box color has been changed to yellow in line with the Class of Recommendation change from Class 2b to Class 2a. Sixth row, an orange box has been added to become the fourth box with the text, "TEE, Cardiac CT, or Cardiac MRI (Class 2b)." Sixth row, the fifth box read, "Evaluate for other rare causes of stroke (Class 2b)." it has been updated to read, "Evaluate for other rare causes of stroke," and the color has been removed in line with removal of the text "(Class 2b)." The revised figure is included below. 3. On page e386, right column, second paragraph, the first sentence read, "1. The REDUCE-IT trial (Reduction of Cardiovascular Events With Icosapent Ethyl–Insstervention Trial) 219 ...." It has been updated to read, "1. The REDUCE-IT trial (Reduction of Cardiovascular Events With Icosapent Ethyl–Intervention Trial) 219 ...." Download figure Download PowerPoint These corrections have been made to the current online version of the article, which is available at https://www.ahajournals.org/doi/10.1161/STR.0000000000000375 .

Corrigendum to: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Correction to: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association.

Pulmonary embolism - An EFIM guideline critical appraisal and adaptation for practicing clinicians

Pulmonary embolism: a practical approach to update risk stratification and treatment decisions based on the guidelines

Correction: Emergency Point-of-Care Ultrasound Stewardship – A Joint Position Paper by EuSEM and EFSUMB and Endorsed by IFEM and WFUMB

Corrigendum to "Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events" [Int. J. Cardiol. Cardiovasc. Risk and Prev. 2023 Jun 25:18:200193]

Erratum to 'Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress' [Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 4, May 2024, 102432]

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Pulmonary Embolism: An Update Based on the Revised AWMF-S2k Guideline

Correction to: Intracoronary imaging to guide percutaneous coronary intervention: from evidence to guidelines; Controversy in cardiology: clopidogrel or acetylsalicylic acid in the treatment of chronic coronary syndromes?

ERRATUM to ESO guideline for the management of extracranial and intracranial artery dissection

ACR Appropriateness Criteria® Suspected Pulmonary Embolism: 2022 Update

Intensive Care Treatment of Pulmonary Embolism: An Update Based on the Revised AWMF S2k Guideline

Corrigendum: Iatrogenic air embolism: pathoanatomy, thromboinflammation, endotheliopathy, and therapies

Corrigendum: Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis

Post–Pulmonary Embolism Syndrome: An Update Based on the Revised AWMF-S2k Guideline

Erratum to: Reliability of the Mangled Extremity Severity Score in the Management of Peripheral Vascular Injuries in Children: A Retrospective Review